DarioHealth Corp.

The momentum for this stock is not very good. DarioHealth Corp. is not a good value stock. DarioHealth Corp. is not very popular among insiders. DarioHealth Corp. is a mediocre stock to choose.

DarioHealth Corp. engages in the research, development, and sale of pharmaceutical products. It prov...

News

Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes

PR Newswire Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes Dario Introduces Integration of Twill Behavioral...\n more…

DarioHealth's cardiometabolic solution in diabetes featured in published study

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes

PR Newswire Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes Dario Publishes New Research...\n more…

DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts DarioHealth Corp. (DRIO) Q2 2024 Earnings Call Transcript...\n more…

DarioHealth (NASDAQ:DRIO) Issues Quarterly Earnings Results

Ticker Report DarioHealth (NASDAQ:DRIO - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.51) by...\n more…

Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 30% Lower

Simply Wall St Unfortunately for some shareholders, the DarioHealth Corp. ( NASDAQ:DRIO ) share price has dived 30% in the last thirty...\n more…